Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-18-025318

Senior VP, Drug Discovery sold 3,000 shares at $55.00 ($165,000)

  • Senior VP, Drug Discovery acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Vargeese Chandra · Senior VP, Drug Discovery

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2018-09-24 Exercise or conversion : show line 1 in the form +3,000 $2.48 $7,440 30,300 D
2018-09-24 Sale : show line 2 in the form −3,000 $55.00 $165,000 27,300 D
Open-market sales · 3,000 sh · avg $55.00 · $165,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-09-24 Exercise or conversion : show line 3 in the form Share Option (right to buy) −3,000 149,542 D
Loading xslF345X03/doc4.xml…